[go: up one dir, main page]

FI933398L - Difenyloxazol-, tiazol- och imidazolderivat, vilka haemmar aoterupptagning av adenosin - Google Patents

Difenyloxazol-, tiazol- och imidazolderivat, vilka haemmar aoterupptagning av adenosin Download PDF

Info

Publication number
FI933398L
FI933398L FI933398A FI933398A FI933398L FI 933398 L FI933398 L FI 933398L FI 933398 A FI933398 A FI 933398A FI 933398 A FI933398 A FI 933398A FI 933398 L FI933398 L FI 933398L
Authority
FI
Finland
Prior art keywords
imidazolderivat
haemmar
aoterupptagning
vilka
adenosin
Prior art date
Application number
FI933398A
Other languages
English (en)
Other versions
FI933398A0 (fi
Inventor
Neelakantan Balasubramanian
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of FI933398A0 publication Critical patent/FI933398A0/fi
Publication of FI933398L publication Critical patent/FI933398L/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/14Radicals substituted by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/28Radicals substituted by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
FI933398A 1992-07-31 1993-07-29 Difenyloxazol-, tiazol- och imidazolderivat, vilka haemmar aoterupptagning av adenosin FI933398L (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US92339992A 1992-07-31 1992-07-31
US4833893A 1993-04-15 1993-04-15

Publications (2)

Publication Number Publication Date
FI933398A0 FI933398A0 (fi) 1993-07-29
FI933398L true FI933398L (fi) 1994-02-01

Family

ID=26726027

Family Applications (1)

Application Number Title Priority Date Filing Date
FI933398A FI933398L (fi) 1992-07-31 1993-07-29 Difenyloxazol-, tiazol- och imidazolderivat, vilka haemmar aoterupptagning av adenosin

Country Status (20)

Country Link
US (1) US5382584A (fi)
EP (1) EP0582164B1 (fi)
JP (1) JP3478852B2 (fi)
KR (1) KR940005614A (fi)
CN (1) CN1085216A (fi)
AT (1) ATE174913T1 (fi)
AU (1) AU670953B2 (fi)
CA (1) CA2101311A1 (fi)
DE (1) DE69322707T2 (fi)
DK (1) DK0582164T3 (fi)
ES (1) ES2125285T3 (fi)
FI (1) FI933398L (fi)
GR (1) GR3029778T3 (fi)
HK (1) HK1014714A1 (fi)
HU (1) HUT67460A (fi)
IL (1) IL106490A0 (fi)
MX (1) MX9304547A (fi)
NO (1) NO932694L (fi)
PL (1) PL299888A1 (fi)
TW (1) TW224096B (fi)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5656762A (en) 1990-12-28 1997-08-12 Neurogen Corporation 4-piperidino-and piperazinomethyl-2-phenylimidazole derivatives, dopamine receptor subtype specific ligands
US5312925A (en) * 1992-09-01 1994-05-17 Pfizer Inc. Monohydrate of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)-ethyl)-6-chloro-1,3-dihydro-2H-indol-2-one-hydrochloride
WO1996016049A1 (en) * 1994-11-23 1996-05-30 Glaxo Wellcome Inc. OXAZOLE DERIVATIVES AS ANTAGONISTS OF α-1C ADRENERGIC RECEPTORS
AU6167696A (en) * 1995-06-07 1996-12-30 Dade Chemistry Systems Inc. Preparation of immunogens and other conjugates of drugs
US5700826A (en) * 1995-06-07 1997-12-23 Ontogen Corporation 1,2,4,5-tetra substituted imidazoles as modulators of multi-drug resistance
CA2250587A1 (en) * 1996-04-03 1997-10-09 Christopher J. Dinsmore Inhibitors of farnesyl-protein transferase
US5866574A (en) * 1997-04-10 1999-02-02 Kyowa Hakko Kogyo Co., Ltd. Pancreatitis remedy
US5840721A (en) * 1997-07-09 1998-11-24 Ontogen Corporation Imidazole derivatives as MDR modulators
PE20000354A1 (es) 1998-04-03 2000-05-20 Advanced Medicine Inc Nuevos compuestos y usos anestesicos locales
US6462034B1 (en) 1998-04-03 2002-10-08 Theravance, Inc. Local anesthetic compounds and uses
US7582680B1 (en) * 1998-11-12 2009-09-01 Purdue Research Foundation Methods and compositions for treating mammalian spinal cord injuries
US7265115B2 (en) 1999-01-29 2007-09-04 Abbott Laboratories Diazabicyclic CNS active agents
DE19924819A1 (de) * 1999-05-29 2000-11-30 Bayer Ag Substituierte Phenylcyclohexancarbonsäurebenzylamid (Adenosinaufnahmeinhibitoren)
DE19924818A1 (de) 1999-05-29 2000-11-30 Bayer Ag Substituierte Phenylcyclohexancarbonsäureamide
AU5125200A (en) * 1999-06-03 2000-12-28 Eli Lilly And Company Process for preparing a 10,11-methanodibenzosuberane derivative
TWI258462B (en) 1999-12-17 2006-07-21 Astrazeneca Ab Adamantane derivative compounds, process for preparing the same and pharmaceutical composition comprising the same
SE9904738D0 (sv) * 1999-12-22 1999-12-22 Astra Pharma Prod Novel compounds
US6809105B2 (en) 2000-04-27 2004-10-26 Abbott Laboratories Diazabicyclic central nervous system active agents
DE10044792A1 (de) 2000-09-11 2002-04-04 Bayer Ag Substituierte Phenylcyclohexancarbonsäureamide und ihre Verwendung
PE20020420A1 (es) 2000-10-02 2002-06-27 Novartis Ag Derivados de diazacicloalcanodiona como antagonistas del antigeno asociado a la funcion del linfocito-1 (lfa-1)
JPWO2002076962A1 (ja) * 2001-03-23 2004-07-15 日本曹達株式会社 3−オキソ−2−(2−チアゾリル)プロパンニトリルの製造方法および中間体
NZ543953A (en) 2001-04-24 2007-04-27 Univ Chicago Method and compositions for treating mammalian nerve tissue injuries
US6649761B2 (en) * 2001-05-30 2003-11-18 Merck & Co., Inc. Process for preparing piperazinepentaneamide HIV protease inhibitors
DE10150310A1 (de) * 2001-10-11 2003-04-24 Bayer Ag Substituierte Piperazincyclohexancarbonsäureamide und ihre Verwendung
CN1326846C (zh) * 2002-06-24 2007-07-18 詹森药业有限公司 生产n-(2,6-二甲基苯基)-2-哌嗪-1-基乙酰胺的方法
KR100694181B1 (ko) * 2005-11-25 2007-03-12 연세대학교 산학협력단 근원세포 또는 근섬유로부터 신경세포 분화를 유도하는화합물, 이를 포함하는 약학적 조성물, 신경세포 분화를유도하는 방법 및 신경세포 분화를 유도하는 화합물을검색하는 스크리닝 방법
TW201113280A (en) 2009-07-03 2011-04-16 Nensius Res As Aminoalkamides for use in the treatment of inflammatory, degenerative or demyelinating diseases of the CNS
KR101423176B1 (ko) 2011-11-29 2014-07-25 제일모직 주식회사 포지티브형 감광성 수지 조성물, 이를 사용하여 제조된 감광성 수지막 및 상기 감광성 수지막을 포함하는 반도체 소자
KR101432603B1 (ko) 2011-12-29 2014-08-21 제일모직주식회사 감광성 노볼락 수지, 이를 포함하는 포지티브형 감광성 수지 조성물, 이를 사용하여 제조된 감광성 수지막 및 이를 포함하는 반도체 소자
EA201790806A1 (ru) 2014-11-05 2017-11-30 Флексус Байосайенсиз, Инк. Иммунорегулирующие средства
UY36390A (es) 2014-11-05 2016-06-01 Flexus Biosciences Inc Compuestos moduladores de la enzima indolamina 2,3-dioxigenasa (ido), sus métodos de síntesis y composiciones farmacéuticas que los contienen
CN109456285A (zh) * 2018-10-29 2019-03-12 安徽省庆云医药股份有限公司 一种雷诺嗪的制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL137318C (fi) * 1964-06-09
US4020082A (en) * 1970-02-21 1977-04-26 Enzo Marchetti 2-Aminomethyl- and 2-(2-aminoethyl)-substituted 4,5-diphenyloxazoles
IT1033040B (it) * 1970-02-21 1979-07-10 Serono Ist Farm 4 5 difenilossazoli 2 amminometil e 2,2 amminoetil sostituiti
GB1527483A (en) * 1976-02-12 1978-10-04 Mitsubishi Chem Ind 2-aminomethyl-5-phenyloxazoles and the pharmaceutically acceptable acid addition salts thereof
FR2459242A1 (fr) * 1979-06-21 1981-01-09 Delalande Sa Derives du benzimidazole portant en position 1 une chaine aralkyle substituee, leur procede de preparation et leur application en therapeutique
US4766125A (en) * 1981-06-23 1988-08-23 Janssen Pharmaceutica N.V. N-aryl-piperazinealkanamides useful for protecting hearts from myocardial injury caused by ischaemia, anoxia or hypoxia
NZ223847A (en) * 1987-04-01 1989-12-21 Janssen Pharmaceutica Nv Substituted piperazine derivatives and pharmaceutical compositions
JP2852659B2 (ja) * 1988-03-03 1999-02-03 富山化学工業株式会社 ピペラジン誘導体およびその塩
JP3003148B2 (ja) * 1989-01-05 2000-01-24 藤沢薬品工業株式会社 チアゾール化合物、その製造法およびそれを含有する医薬組成物
CA2012716A1 (en) * 1989-03-22 1990-09-22 Akito Tanaka Thiazole compounds, processes for the preparation thereof and pharmaceutical composition comprising the same
JPH05506842A (ja) * 1989-09-15 1993-10-07 ジェンシア・ファーマシュウティカルズ・インコーポレイテッド 神経変性状態の処置方法
EP0618905B1 (en) * 1991-12-18 1995-10-04 Schering Corporation Imidazolyl-alkyl-piperazine and -diazepine derivatives as histamine h3 agonists/antagonists

Also Published As

Publication number Publication date
EP0582164B1 (en) 1998-12-23
AU670953B2 (en) 1996-08-08
CN1085216A (zh) 1994-04-13
DE69322707D1 (de) 1999-02-04
NO932694L (no) 1994-02-01
IL106490A0 (en) 1993-11-15
HUT67460A (en) 1995-04-28
US5382584A (en) 1995-01-17
DK0582164T3 (da) 1999-08-23
MX9304547A (es) 1994-02-28
DE69322707T2 (de) 1999-08-19
PL299888A1 (en) 1994-04-18
EP0582164A1 (en) 1994-02-09
TW224096B (fi) 1994-05-21
ES2125285T3 (es) 1999-03-01
CA2101311A1 (en) 1994-02-01
FI933398A0 (fi) 1993-07-29
ATE174913T1 (de) 1999-01-15
JPH06157472A (ja) 1994-06-03
HK1014714A1 (en) 1999-09-30
AU4423293A (en) 1994-02-03
NO932694D0 (no) 1993-07-27
GR3029778T3 (en) 1999-06-30
JP3478852B2 (ja) 2003-12-15
KR940005614A (ko) 1994-03-21

Similar Documents

Publication Publication Date Title
FI933398L (fi) Difenyloxazol-, tiazol- och imidazolderivat, vilka haemmar aoterupptagning av adenosin
FI934861L (fi) Foerfarande foer framstaellning av 3a-hydroxi, 3b-substituerade pregnaner
FI931142L (fi) Anordning foer vaermebehandling av oftalmiska linser, speciellt kontaktlinser
FI931180L (fi) Verktyg foer kallformning av plast-folier, speciellt polypropylenfoliermed olika tjocklek
FI920011A0 (fi) Av roerformade delar bildat vaeggelement.
FI920550A0 (fi) Foerfarande foer framstaellning av skivformiga konstruktionselement.
FI293U1 (fi) Anordning foer behandlig av foerpackningar, saosom flaskor
FI512U1 (fi) Anordning foer behandling av foerpackningar, saosom flaskor
FI513U1 (fi) Anordning foer behandling av foerpackningar, saosom flaskor
FI605U1 (fi) Anordning foer ombyte av vaetska i mellanrummet av en dubbelmantlad, i maerken nedsaenkbar vaetskebehaollare
FI922148A0 (fi) Anordning foer detektering av laeckage.
FI921257A0 (fi) Foerfarande foer avskiljning av vatten fraon vaetskor medelst elektrisk mikrofiltrering.
FI923040A0 (fi) Foerfarande foer reducering av utslaepp fraon fordon.
FI923039A0 (fi) Foerfarande foer reducering av utslaepp fraon kraftverk.
FI922915A0 (fi) Circulering av avfallsvatten.
FI922795A0 (fi) Anordning foer mottagning av en rullande pappersrulle.
FI922755A0 (fi) Parkeringsplattform av modul- konstruktion.
FI922634A0 (fi) Foerfarande foer maetning av joniserande straolning.
FI922466A0 (fi) Foerfarande foer torkning av spannmaol.
FI921090A0 (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara cykloalkyl- och azacykloalkylpyrrolo- pyrimidiner.
FI922118A0 (fi) Anordning foer vridning av graevmaskins- skopa.
FI922035A0 (fi) Anordning foer avlaegsnande av skydd fraon wc-sits.
FI922032A0 (fi) Anordning foer hantering av rundbalar.
FI921656A0 (fi) Friktionsbandsystem foer foerbaettrande av daeckets faestfoermaoga.
FI921519A0 (fi) Foerfarande foer torkning av normala tryckfaerger.